An interventional study of High-Intensity Progressive Inspiratory Muscle Training (IMT) in Obesity, Class III, Sleep Apnea, Obstructive and Inspiratory Muscle Training, sponsored by University of the State of Santa Catarina. Not yet recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-23.
Sponsored by University of the State of Santa Catarina · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 285 studies in Obesity with a site in Brazil — 41 open to participants now, 61 under way, 27 of them phase 3. Obesity · Brazil.
Among the 285 studies in Obesity with a site in Brazil, this one is the 237th largest by planned enrollment of the 251 interventional ones that give a count, is one of 29 that started in 2026, is one of 170 with no phase, reaches primary completion later than 30 of the 60 other live ones, and was the 265th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →41 of the 285 studies in Obesity with a site in Brazil are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Brazil, United States, Argentina and 8 more countries
Ages 18+
Universidade Cesumar (UNICESUMAR) · Sites in Brazil
Ages 60+
AstraZeneca · Sites in Brazil, United States, Argentina and 8 more countries
Ages 18+
AstraZeneca · Sites in Brazil, United States, Argentina and 13 more countries
Ages 18+
Pfizer · Sites in Brazil, United States, Canada and 8 more countries
Ages 18+
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
285 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 11 · Phase 2 12 · Phase 3 55 · Phase 4 9
First in 2001; this study’s year is marked. 29 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 60 across the 251 interventional studies, 55 across the 32 observational. Of the 164 that completed or were terminated, 15 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
57 of 285 have an industry lead sponsor. The 10 most frequent:
University of the State of Santa Catarina is the lead sponsor of 25 studies on the registry; 6 are open to participants now.
University of the State of Santa Catarina has 1 study filed under Obesity — fewer than ten, so there is no comparison to draw.
18 of the studies in Obesity with a site in Brazil that are under way reach primary completion within a year, 6 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06914895Phase 3Eli Lilly and CompanyA Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight | 2026-11 |
| NCT06962280Phase 3Eli Lilly and CompanyA Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight | 2026-11 |
| NCT06672549Phase 3Eli Lilly and CompanyA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) | 2027-02 |
| NCT07225686Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy | 2027-08-20 |
| NCT07226765Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy | 2027-08-30 |
Add all 18 to your calendar (.ics) → With an account.
Among the 285 studies in Obesity with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the feasibility and effects of a 12-week high-intensity progressive Inspiratory Muscle Training (IMT) program in individuals with Class III obesity (BMI ≥ 40 kg/m²) and obstructive sleep apnea (OSA). Using a single-case experimental design (SCED) with multiple baselines, the study will investigate whether this respiratory intervention can reduce the severity of sleep apnea, as measured by the Apnea-Hypopnea Index (AHI), and improve inspiratory muscle strength and sleep quality. Participants will perform daily training sessions using a resistive loading device (POWERbreathe), with intensity progressing from 40% to 90% of their maximum inspiratory pressure.
Inclusion Criteria: -Adults (≥18 years).
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will undergo a progressive high-intensity Inspiratory Muscle Training (IMT) program using a resistive loading device (POWERbreathe).
Device: High-Intensity Progressive Inspiratory Muscle Training (IMT)
"The intervention consists of 12 weeks of inspiratory muscle training performed 5 days per week. Each session includes 30 breaths through a resistive loading device (POWERbreathe). The training intensity starts at 40% of the Maximum Inspiratory Pressure (MIP) and progressively increases to 90% of MIP. Training load is adjusted weekly based on new MIP measurements to ensure high-intensity stimulus. Compliance and adverse events will be monitored through a training diary."
Apnea-Hypopnea Index (AHI)
Number of apnea and hypopnea events per hour of sleep, measured via portable polygraphy (Type III)
Time frame: Baseline (Phase A - three measurements) and Post-Intervention (Phase B - 12th week).
Maximum Inspiratory Pressure (MIP)
Assessment of inspiratory muscle strength using a digital pressure manometer.
Time frame: Weekly assessments throughout Phase A (3 to 5 weeks) and Phase B (12 weeks).
Epworth Sleepiness Scale (ESS) score
Validated questionnaire to assess the level of daytime sleepiness. Scores range from 0 to 24, where higher scores indicate greater sleepiness.
Time frame: Baseline and Post-Intervention (12th week).
Pittsburgh Sleep Quality Index (PSQI) global score
Questionnaire to assess sleep quality over a one-month period. Scores range from 0 to 21; higher scores indicate poorer sleep quality.
Time frame: Baseline and Post-Intervention (12th week).
International Physical Activity Questionnaire (IPAQ) - Short Form
Assessment of physical activity level. It classifies participants as sedentary, irregularly active, active, or very active based on metabolic equivalent task (MET-min/week).
Time frame: Baseline and Post-Intervention (12th week).
Borg Rating of Perceived Exertion (RPE)
Scale ranging from 6 to 20 used to monitor the intensity of the respiratory effort during the IMT sessions.
Time frame: Daily during the 12 weeks of intervention (Phase B).
Quebec Sleep Questionnaire (QSQ)
A disease-specific quality of life questionnaire for obstructive sleep apnea. It consists of 32 items divided into five domains: daytime sleepiness, diurnal symptoms, nocturnal symptoms, emotions, and social interactions. Each item is scored on a 7-point Likert scale, where higher scores indicate better quality of life.
Time frame: Baseline (Phase A) and Post-Intervention (12th week of Phase B).
Plan to share: No
Start is estimated for May 2026; primary completion for May 2027, 12 months later.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 12 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of the State of Santa Catarina